Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone increases acidification in the vas deferens by up-regulating V-ATPase.

Thyroid dysfunction, vitamin D and B12 deficiencies, and iron deficiency may be linked to hair loss condition Telogen Effluvium.

Testosterone increases heart and blood pressure issues in rats with endotoxemia, and stopping testosterone production can reduce these problems.

Being overweight, having gallbladder removal surgery, and taking cholesterol-lowering drugs are linked to a higher chance of getting vulvar lichen sclerosus.

Surgical and chemical castration have varied effects on heart and brain inflammation and artery function in sick rats.

Microneedles are effective for painless drug delivery and promoting wound healing and tissue regeneration.

Androgens play a key role in causing PCOS (Polycystic Ovary Syndrome).

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.

Balding men had lower bone density, while balding women had higher hip bone density.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Testosterone raises blood pressure and changes kidney protein levels.

Antiandrogens help manage PCOS symptoms but need careful monitoring.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

Current alopecia treatments manage symptoms but don't cure, and better treatments are needed.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

New gene discoveries have improved diagnosis and treatment for skin and hair disorders, but more research is needed to fully understand them.

Taurine is important for many body functions and its deficiency can cause health problems.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

The Shen Bai Hair Growing Decoction may help treat hair loss by promoting hair growth and reducing inflammation.

Cimetidine did not reduce hair growth in women with hirsutism.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

A cream with a specific hormone blocker increases hair growth in mice.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

Blocking Wnt/β-catenin signaling with EGF receptor is necessary for proper hair growth.

Testosterone affects stress hormone levels differently in adolescent and adult male rats.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.